Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP7338134B2 - Virus disinfection effect determination method and antiviral disinfectant selected by the determination method - Google Patents
[go: Go Back, main page]

JP7338134B2 - Virus disinfection effect determination method and antiviral disinfectant selected by the determination method - Google Patents

Virus disinfection effect determination method and antiviral disinfectant selected by the determination method Download PDF

Info

Publication number
JP7338134B2
JP7338134B2 JP2018167537A JP2018167537A JP7338134B2 JP 7338134 B2 JP7338134 B2 JP 7338134B2 JP 2018167537 A JP2018167537 A JP 2018167537A JP 2018167537 A JP2018167537 A JP 2018167537A JP 7338134 B2 JP7338134 B2 JP 7338134B2
Authority
JP
Japan
Prior art keywords
virus
effect
disinfection
viruses
addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018167537A
Other languages
Japanese (ja)
Other versions
JP2020039263A (en
Inventor
直行 西村
秀友 佐守
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kten Bio
Original Assignee
Kten Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kten Bio filed Critical Kten Bio
Priority to JP2018167537A priority Critical patent/JP7338134B2/en
Publication of JP2020039263A publication Critical patent/JP2020039263A/en
Application granted granted Critical
Publication of JP7338134B2 publication Critical patent/JP7338134B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Description

本発明は、(1)環境(施設やその内の設備、機材、器具などのほか、食品材料、生物材料なども含む)に存在するウイルスを濃縮して検出する、(2)検出された場合には標的とするウイルスとそれが存在する環境に適した消毒剤と消毒方法で消毒する、(3)消毒後、ウイルスが消滅したかどうかの確認検査を行う。これらの一連のシステムを構築するための方法やそれに使用する試薬などを開発、整備することで、ウイルス(特に病原性ウイルス)による環境汚染を防ぎ、これらを介した生物(特にヒト)へのウイルス感染に対する防御力を高めることができる。 The present invention (1) concentrates and detects viruses present in the environment (including facilities, equipment, equipment, instruments, etc. in them, as well as food materials and biological materials), and (2) when detected (3) After disinfection, conduct a confirmation test to see if the virus has disappeared. By developing and maintaining the methods for constructing these series of systems and the reagents used for them, we can prevent environmental pollution by viruses (especially pathogenic viruses) and spread viruses to organisms (especially humans) through these. You can increase your defense against infection.

生物に病気を引き起こす病原性ウイルスは世の中に多々存在するが、特にヒトに感染し、重篤な病気を引き起こす病原性ウイルスによる主な疾患には、エイズ、痘瘡、ポリオ、ウイルス性肝炎、日本脳炎、麻疹、狂犬病、トラコーマ、鼠径リンパ肉眼腫、インフルエンザ(特に高病原性)などが挙げられる。 There are many pathogenic viruses that cause disease in living organisms, but the main diseases caused by pathogenic viruses that infect humans and cause serious illness include AIDS, smallpox, polio, viral hepatitis, and Japanese encephalitis. , measles, rabies, trachoma, inguinal lymphoma, and influenza (especially highly pathogenic).

また、前記の病原性ウイルスに比べると重篤度は低いが、日々の生活(特に食生活)を通じて頻繁に生じるのはウイルスが原因の食中毒である。 Food poisoning caused by viruses frequently occurs in daily life (especially diet), although it is less serious than the pathogenic viruses described above.

食中毒を引き起こす病原性ウイルスのなかでも、我が国で冬季から春先に掛けて多発する食中毒の原因となるのがノロウイルス(以下、NV)である。NVは7つの遺伝子群 (GI~GVII)に分類されており、その内、ヒトに感染し胃腸炎を引き起こすのはGI,GIIおよびGIVであるが、近年GII(特にGII.4型)が主要流行株となっている。NVは感染性食中毒原因全体の70%程度を占めていて、毎年1~3万人の感染者が報告されているが、実際にはその100倍程度が感染していると推測されている。 Among the pathogenic viruses that cause food poisoning, norovirus (NV) is the cause of food poisoning that frequently occurs in Japan from winter to early spring. NV is classified into seven gene groups (GI to GVII), of which GI, GII and GIV cause gastroenteritis in humans, but recently GII (especially GII.4 type) is the main one. It has become a popular stock. NV accounts for about 70% of all infectious food poisoning causes, and although 10,000 to 30,000 people are reported to be infected each year, it is estimated that about 100 times that number are actually infected.

NVの感染経路としては、(1)下水→貝類→人、(2)調理従事者→器具・食材→人、(3)人→人、人→施設環境→人が想定されており、従来は(1)経路が大半を占めていたが、近年は (2)、(3)の人を介した汚染による感染事例が大半を占めるようになってきている。 NV infection routes are assumed to be (1) sewage → shellfish → people, (2) cooking workers → utensils / ingredients → people, (3) people → people, people → facility environment → people. Although (1) route accounted for the majority, in recent years, (2) and (3) infection cases due to contamination via humans have come to account for the majority.

このようにNVが蔓延する原因としては、以下のNVが有している特徴が大きく関与していると考えられている。即ち、(1)NVの遺伝子本体がRNAで変異が生じ易く、かつNVに対する免疫防御が腸粘膜を介したものであるため、一度感染したとしても免疫が無効もしくは長続きしない。(2)糞便のみならず嘔吐物中にも大量のウイルスが排出される(患者便中105~109ウイルス/g、患者嘔吐物中103~107ウイルス/g)。(3)感染者は症状消失後も長期に渡ってNVを排出し続ける(成人で3週間、小児では1ヶ月以上排出されたとの報告がある)。(4)症状の出ない感染者(不顕性感染者)が多数存在するが、彼らも人に感染させるに足る量のNVを糞便中に排出している。(5)100~1,000 NVの曝露で半数の人が感染するほど感染力が強い。(6)環境中(特に低温での)生存期間が長い(乾燥状態の4℃保存で2ヶ月、20℃保存で1ヶ月程度と推定されている)。 It is believed that the following characteristics of NV are largely responsible for the spread of NV. Namely, (1) the NV gene body is RNA, which is susceptible to mutation, and immune defense against NV is mediated by the intestinal mucosa; therefore, once infected, immunity is ineffective or does not last long. (2) A large amount of virus is excreted not only in feces but also in vomit (10 5 -10 9 virus/g in patient stool, 10 3 -10 7 virus/g in patient vomit). (3) Infected individuals continue to shed NV for a long period of time even after symptoms have disappeared (it has been reported that adults shed NV for 3 weeks and children shed more than 1 month). (4) There are many infected people who do not show symptoms (inapparently infected people), but they also excrete NV in their feces in an amount sufficient to infect humans. (5) It is so contagious that half of the people are infected by exposure to 100 to 1,000 NV. (6) It has a long survival period in the environment (especially at low temperatures) (estimated to be about 2 months when stored in a dry state at 4°C and about 1 month when stored at 20°C).

そのような状況から、同一メニューを1回300食以上又は1日750食以上を提供する調理施設(大量調理施設)を対象とした「大量調理施設衛生管理マニュアル」(平成9年3月24日付け衛食第85号別添 最終改正:平成29年6月16日付け食安発0610第1号)の平成20年6月の改訂で、厚生労働省は「NV検便検査」や「NV感染者の調理作業控え」などの推奨を追記した。 Under such circumstances, the "Manual for Hygiene Management of Mass Cooking Facilities" (March 24, 1997) is intended for cooking facilities (mass cooking facilities) that provide 300 or more meals of the same menu at one time or 750 or more meals per day. Tsukeei-shoku No. 85 Attachment Final revision: In June 2008 revision of the June 16, 2017 Shokuan Notification No. 0610-1), the Ministry of Health, Labor and Welfare announced "NV stool test" Recommendations such as "Refrain from cooking work" were added.

しかしながら、食中毒発生原因として未だNVは全体の2/3程度を占めている。さらに、
発生施設は、飲食店、仕出し屋、旅館、製造所などの食品を直接取り扱う施設に加えて、事業所、学校、病院、販売所、家庭など多岐に渡っている。
However, NV still accounts for about two-thirds of all food poisoning cases. moreover,
In addition to facilities that directly handle food such as restaurants, caterers, inns, and factories, the outbreak facilities are diverse, including offices, schools, hospitals, sales offices, and homes.

従って、NV感染を予防するには、従来のNV検便検査(個別検査)に加えて、食品
取り扱い場所も含めたNV汚染が疑われる場所でのNVの検査さらにはモニタリングなどでの広域(環境)検査が極めて有効と考えられた。
Therefore, in order to prevent NV infection, in addition to the conventional NV stool test (individual test), food
Wide-area (environmental) inspections such as NV inspections and monitoring in locations where NV contamination is suspected, including handling locations, were considered to be extremely effective.

さて、環境中のウイルス検査においては、まずは、ウイルス汚染が懸念される場所での設備、機材、器具、食材などをリン酸緩衝液などの緩衝液、生理食塩水、もしくは蒸留水を含浸させた綿棒などを用いて拭き取る。 Now, in the virus test in the environment, first, equipment, equipment, instruments, foodstuffs, etc. in places where virus contamination is a concern are impregnated with a buffer solution such as phosphate buffer, physiological saline, or distilled water. Wipe off with a cotton swab or the like.

拭き取ったウイルスは、拭き取り治具に包含した緩衝液、生理食塩水や蒸留水に懸濁した後、ポリエチレングリコール (以下、PEG)などを含んだ濃縮液と混合しての遠心、あるいは懸濁液から直接に超遠心などで濃縮される。 The wiped virus is suspended in a buffer solution, physiological saline, or distilled water contained in a wiping jig, then mixed with a concentrated solution containing polyethylene glycol (hereinafter referred to as PEG) and centrifuged, or suspended. It is directly concentrated by ultracentrifugation.

濃縮物中にウイルスが存在するか否かを確認するには、ウイルスから直接もしくはその遺伝子(核酸:DNAもしくはRNA)を抽出・精製した後、そのウイルス遺伝子がDNAの場合はPCRなどでそのDNAを増幅、RNAの場合は、RNAそのものを増幅、あるいは逆転写(RT)反応でDNAに転換してから増幅する。増幅物の検出や解析はプローブ法などでリアルタイムに、もしくは増幅後、融解温度解析 (Melting Curve Analysis : MCA)やアガロース電気泳動などで行う、いわゆる遺伝子検査が実施されている。 To confirm whether the virus is present in the concentrate, directly from the virus or after extracting and purifying its gene (nucleic acid: DNA or RNA), if the viral gene is DNA, the DNA is analyzed by PCR or the like. In the case of RNA, the RNA itself is amplified, or it is converted to DNA by reverse transcription (RT) reaction and then amplified. Amplified products are detected and analyzed in real time by a probe method or the like, or after amplification, a so-called genetic test is performed by melting temperature analysis (MCA), agarose electrophoresis, or the like.

しかしながら、従来のPEG沈殿法では、ウイルスを高率かつ安定的に回収することが困難でかつ作業工程が煩雑、工程時間も長く、簡便・迅速かつ高回収率にウイルスを濃縮することができなかった。また、超遠心法は、装置が高価な上に、操作には熟練した技術が必要であり、一度に処理できる検体数も少ないなど、汎用面での問題が大きかった。 However, with the conventional PEG precipitation method, it is difficult to recover the virus at a high rate and in a stable manner, the work process is complicated, the process takes a long time, and the virus cannot be concentrated easily, quickly, and at a high recovery rate. Ta. In addition, the ultracentrifugation method has large problems in terms of versatility, for example, the apparatus is expensive, the operation requires skill, and the number of specimens that can be processed at one time is small.

そこで、我々は、PEG溶液への多糖類添加と添加量の最適化、および添加塩濃度の最適化により、水溶液中のウイルスを簡便・迅速かつ安定的に高回収率で濃縮する方法およびそれに使用する試薬を発明して特許出願を行った(特願2018-126772号)。 Therefore, by optimizing the addition and amount of polysaccharide to the PEG solution and the concentration of the added salt, we developed a method for concentrating viruses in an aqueous solution simply, quickly, and stably with a high recovery rate, and its use. He invented a reagent that does so and filed a patent application (Japanese Patent Application No. 2018-126772).

上記の方法を利用して環境から高率に回収したウイルスは、ダイレクト(核酸の抽出・精製をすることなく)に、検出すべき核酸がDNAの場合はPCRなど、RNAの場合は逆転写(RT)反応でcDNAに転換後PCRなどで増幅・検出することで、環境中に存在するウイルスの検出やモニタリングを高速かつ容易に行えるようになった。 Viruses collected from the environment at a high rate using the above methods are directly (without nucleic acid extraction/purification) subjected to PCR, etc. when the nucleic acid to be detected is DNA, and reverse transcription (for RNA). After conversion to cDNA by RT) reaction, amplification and detection by PCR etc. has made it possible to detect and monitor viruses existing in the environment at high speed and easily.

さて、検査対象物からウイルスが検出された場合には消毒が必要となる。ウイルスに対する消毒効果を謳う消毒剤は数多く存在しているが、培養が困難なウイルスに対しては、培養が可能な近縁ウイルス(NVに対してはマウスノロウイルスやネコカリシウイルス)を代替えとした培養法で効果判定を行い、実際のターゲットに対する効果を推定して使用されているのが現状である(特許文献1、非特許文献1)。
しかし、この方法では、標的とするウイルスを実際の現場で不活化させうるかどうかは不明である。このことは、ウイルスを含む病原微生物の消毒剤として頻繁に使用されている次亜塩素酸ナトリウムなどの塩素系薬剤のように有機物が存在すると効果が激減する消毒剤を使用する場合においてはなおさらのことである。さらに標的とするウイルスを使用して消毒効果を判定した消毒剤を使用する場合においても、培養では効果判定まで長時間を要し、実現場での消毒効果の確認には向いていない。
Now, when a virus is detected from an object to be inspected, disinfection is required. There are many disinfectants that claim to be effective against viruses, but for viruses that are difficult to culture, related viruses that can be cultured (murine norovirus and feline calicivirus for NV) were used as substitutes. Currently, the culture method is used to determine the effect, and the effect on the actual target is estimated and used (Patent Document 1, Non-Patent Document 1).
However, it is unclear whether this method can inactivate the target virus in the actual field. This is especially true when using disinfectants whose effectiveness is greatly reduced in the presence of organic matter, such as chlorine-based agents such as sodium hypochlorite, which are frequently used as disinfectants against pathogenic microorganisms including viruses. That is. Furthermore, even when using a disinfectant whose disinfection effect has been determined using a target virus, culture takes a long time to determine the effect, and is not suitable for confirming the disinfection effect in the actual field.

以上のことなどから、ウイルスによる環境汚染を防ぎ、これらを介した生物へのウイルス感染に対する防御力を高めるには、消毒対象の環境あるいは擬似環境に存在する標的ウイルスでの有効性が証明された消毒剤や消毒法の使用が必須となる。さらに、消毒後は迅速かつ高率なウイルス回収法とダイレクト遺伝子検査のような迅速かつ高感度な検出法を組み合わせて、その消毒効果を迅速かつ高感度に判定することで、さらに防御効果を高めることができる。 From the above, it has been demonstrated that target viruses present in the environment to be disinfected or simulated environments are effective in preventing environmental contamination by viruses and increasing defenses against viral infections of organisms through these. The use of disinfectants and disinfection methods is mandatory. In addition, after disinfection, a rapid and highly efficient virus collection method and a rapid and highly sensitive detection method such as direct genetic testing are combined to rapidly and highly sensitively determine the disinfection effect, further enhancing the defense effect. be able to.

特開2016-210807号公報JP 2016-210807 A

環境感染誌 Vol.31 no.3, 2016 Journal of Environmental Infection Vol.31 no.3, 2016

環境中の検査対象物に存在するウイルスに消毒効果をもたらす薬剤の種類や濃度、その使用法などを、標的ウイルスとそれが存在する環境に合わせて設定する。その上で、(1)検査対象物に存在する標的ウイルスの濃縮・検出を迅速に行う。(2)(1)でウイルスが検出された場合もしくはウイルスによる汚染の可能性が高い場合には、当該ウイルスとそれが存在する環境に適した消毒剤と消毒方法で消毒する。(3)消毒効果の確認検査を迅速に行う。これらの一連のシステムを構築するための方法やそれに使用する試薬、器具や装置類を整備することで、ウイルス(特に病原性ウイルス)による環境汚染を防ぎ、これらを介した生物(特にヒト)へのウイルス感染に対する防御力を高めることができる。 The type, concentration, and method of use of the drug that has a disinfecting effect on the virus present in the test object in the environment are set according to the target virus and the environment in which it exists. In addition, (1) rapid concentration and detection of the target virus present in the test object. (2) If a virus is detected in (1) or if there is a high possibility of virus contamination, disinfect with a disinfectant and disinfection method suitable for the virus and the environment in which it exists. (3) Promptly confirm the disinfection effect. By preparing the methods for constructing these series of systems and the reagents, instruments, and devices used in them, we can prevent environmental pollution by viruses (especially pathogenic viruses) and protect organisms (especially humans) through these. can increase the defense against viral infection of

我々は、先に発明したウイルス濃縮法(特願2018-126772号)のようなウイルスを高率かつ安定的に濃縮して回収する方法が、環境中のウイルス汚染の検査やモニタリング以外に、実際の標的ウイルスとそれが存在する環境に適した消毒剤やその使用法の開発や選択、さらには消毒後の効果確認検査に使用できるのではないかと考え、NVを材料に鋭意検討を重ねてきた。
即ち、本発明は、抗ウイルス消毒剤候補で標的ウイルスを処理した液もしくは該薬剤がRNA増幅反応もしくは逆転写(RT)反応またはPCRなどのDNA増幅反応に影響を及ぼさない範囲まで希釈するか中和した液に、特願2018-126772号で示すポリエチレングリコール(PEG)と多糖類などを含む濃縮液のようなウイルスを高率かつ安定的に濃縮できる液を加え、遠心操作などでウイルスを濃縮する。その後、該濃縮液中の標的ウイルスの遺伝子増幅を行い、消毒剤候補の消毒効果を判定することを特徴とするウイルス消毒効果判定方法である。
希釈液としては、蒸留水や各種緩衝液などが、中和液としては、酸やアルカリなどによるpH中和液の他、チオ硫酸ナトリウムなどによる塩素中和液なども挙げられる。
PEG溶液に添加する多糖類としては、PEG溶液中で懸濁状態になるものであれば使用できる可能性が高い。例として、グルコース由来のアミロペクチン、カードラン、グリコーゲン、セルロース、α-セルロース、デキストリン、N-アセチルグルコサミン由来のキチン、フルクトース由来のイヌリンが挙げられるがこれらに限定されるものではなく、またこれらを混合して使用することも可能である。上記多糖類の内、グリコーゲン、デキストリン、イヌリンが推奨されるが、最も推奨されるのはグリコーゲンである。
We believe that a method for highly efficient and stable concentration and recovery of viruses, such as the previously invented virus concentration method (Japanese Patent Application No. 2018-126772), is actually useful in addition to the inspection and monitoring of viral contamination in the environment. , and the development and selection of disinfectants suitable for the target virus and the environment in which it exists. .
That is, the present invention provides a solution in which the target virus is treated with a candidate antiviral disinfectant, or the agent is diluted or diluted to the extent that it does not affect the RNA amplification reaction, reverse transcription (RT) reaction, or DNA amplification reaction such as PCR. To the mixed liquid, add a liquid that can stably concentrate the virus, such as a concentrate containing polyethylene glycol (PEG) and polysaccharides shown in Japanese Patent Application No. 2018-126772, and concentrate the virus by centrifugation. do. After that, gene amplification of the target virus in the concentrated liquid is carried out, and the disinfection effect of the candidate disinfectant is judged.
Examples of diluents include distilled water and various buffer solutions, and examples of neutralizing solutions include pH-neutralizing solutions such as acids and alkalis, as well as chlorine-neutralizing solutions such as sodium thiosulfate.
As the polysaccharide to be added to the PEG solution, there is a high possibility that any polysaccharide that becomes suspended in the PEG solution can be used. Examples include, but are not limited to, glucose-derived amylopectin, curdlan, glycogen, cellulose, α-cellulose, dextrin, N-acetylglucosamine-derived chitin, fructose-derived inulin, and mixtures thereof. It is also possible to use Among the above polysaccharides, glycogen, dextrin, and inulin are recommended, but glycogen is the most recommended.

さらに具体的には、各種消毒剤候補でNVを処理した後、当該消毒剤がNV遺伝子に影響を与えない(RT-PCRの結果に影響を与えない)濃度以下になるように蒸留水で希釈し、直ちに前記のウイルス濃縮法でウイルスを濃縮した。遠心後の沈渣に検体処理液を加えて加熱後、RNAを精製することなく直接RT-PCR(以下、direct RT-PCR)を行い、蛍光標識probeでリアルタイムに検出する系(以下、消毒効果判定系)で各種消毒剤のNVに対する消毒効果を判定した。
抗ウイルス消毒剤候補としては、細菌やウイルスに対する消毒剤の効果を検討した文献類などを参考に、アルコール系消毒剤、塩素系消毒剤、塩化ベンザルコニウム、グルタルアルデヒド、ペルオキシー硫酸カリウム、メタケイ酸ナトリウム、リン酸三ナトリウム、過酸化水素、加熱などを試してみたが、特に本消毒効果判定系で効果が確認できたのは、塩素系消毒剤とメタケイ酸ナトリウムであった。なお、本評価系が核酸の存在を直接確認する方法を使用していること、加熱処理(85℃ 3分間)したNV懸濁液からは無処理のものからと同量のNV由来RT-PCR産物が得られたこと(data not shown)などから、これらの薬剤はウイルス内部に浸透してRNAを分解、もしくはウイルス殻を壊して内のRNAを放出など、ウイルス内部の核酸に直接もしくは間接的に作用しているものと推定している。また、その推定される作用機序や塩素系薬剤が消毒を目的に広く使用されていることなどから、本消毒効果判定系で見出された薬剤はウイルス全般(特にRNAゲノムを持った)に対する消毒、さらには細菌や真菌などのウイルス以外の微生物をも含めての消毒など、汎用的な消毒剤としての使用も可能と考えている。
More specifically, after treating NV with various disinfectant candidates, dilute with distilled water so that the disinfectant does not affect NV genes (do not affect RT-PCR results) or less. The virus was immediately concentrated by the virus concentration method described above. After the sample treatment solution is added to the sediment after centrifugation and heated, direct RT-PCR (hereinafter referred to as direct RT-PCR) is performed without purifying RNA, and a system that detects in real time with a fluorescently labeled probe (hereinafter referred to as disinfection effect determination system) to determine the antiseptic effect of various antiseptics against NV.
Antiviral disinfectant candidates include alcohol-based disinfectants, chlorine-based disinfectants, benzalkonium chloride, glutaraldehyde, potassium peroxysulfate, and metasilicic acid. Sodium, trisodium phosphate, hydrogen peroxide, and heating were tested, but chlorine-based disinfectants and sodium metasilicate were particularly effective in this disinfection effect evaluation system. In addition, this evaluation system uses a method to directly confirm the presence of nucleic acids, and the same amount of NV-derived RT-PCR From the fact that the product was obtained (data not shown), these drugs directly or indirectly affect the nucleic acid inside the virus, such as penetrating the virus and degrading the RNA, or breaking the virus shell and releasing the RNA inside. It is presumed that In addition, due to its presumed mechanism of action and the fact that chlorine-based agents are widely used for disinfection purposes, the agents found in this disinfection effect determination system are effective against viruses in general (especially those with RNA genomes). We believe that it can also be used as a general-purpose disinfectant, such as disinfection and disinfection of microorganisms other than viruses such as bacteria and fungi.

本消毒効果判定系で効果が見出された消毒剤の内、塩素系の消毒剤については、水溶液中に有機物が存在すると、ウイルス(RNA)減少効果(消毒効果)が激減することが本系においても認められた。例えば、次亜塩素酸ナトリウムは、蒸留水中では0.025%(終濃度)でもNVに対する十分な消毒効果を発揮するものの、有機物として添加したウシ血清アルブミン(BSA)の量が増加するに従いその効果は減弱し、5%BSA(終濃度)存在下では0.1%(終濃度)の次亜塩素酸ナトリウムでもその効果は全く認められなかった。 Among the disinfectants that were found to be effective in this disinfection effect determination system, the presence of organic matter in the aqueous solution of chlorine-based disinfectants drastically reduced the virus (RNA) reduction effect (disinfection effect). was also recognized. For example, sodium hypochlorite exhibits a sufficient antiseptic effect against NV even at 0.025% (final concentration) in distilled water, but the effect diminishes as the amount of bovine serum albumin (BSA) added as an organic substance increases. However, in the presence of 5% BSA (final concentration), no effect was observed even with 0.1% (final concentration) sodium hypochlorite.

他方、メタケイ酸ナトリウムの場合は、0.5%(終濃度)程度からNVに対して消毒効果を示すが、BSA添加の有無によってその消毒効果は影響を受けなかった。さらに、塩素系消毒剤をメタケイ酸ナトリウムとの組み合わせで使用することで、塩素系消毒剤の有機物存在下での消毒効果減弱を補填するのに有効であることも見出した。
これより、本発明は、本発明の判定系により選定された抗ウイルス消毒剤をも提供する。ここで、抗ウイルス消毒剤はアルカリ金属ケイ酸塩を包含することを特徴とする。
アルカリ金属ケイ酸塩は、一般式M2O・xSiO2・yH2O(M:アルカリ金属)で表わされ、ナトリウム、カリウム、リチウムのケイ酸塩を用いることができるが、メタケイ酸ナトリウムが好ましい。メタケイ酸ナトリウムの添加する濃度は、終濃度で0.5%以上、好ましくは3.5%以上、さらに好ましくは11%以上である。
On the other hand, in the case of sodium metasilicate, the antiseptic effect against NV was shown from about 0.5% (final concentration), but the antiseptic effect was not affected by the presence or absence of BSA addition. Furthermore, it was found that the use of a chlorine-based disinfectant in combination with sodium metasilicate is effective in compensating for the weakening of the disinfecting effect of the chlorine-based disinfectant in the presence of organic matter.
Accordingly, the present invention also provides an antiviral disinfectant selected by the determination system of the present invention. Here, the antiviral disinfectant is characterized by containing an alkali metal silicate.
The alkali metal silicate is represented by the general formula M2O.xSiO2.yH2O (M: alkali metal), and silicates of sodium, potassium and lithium can be used, but sodium metasilicate is preferred. The final concentration of sodium metasilicate added is 0.5% or more, preferably 3.5% or more, and more preferably 11% or more.

さらに、今回の発明である標的とするウイルスとそれが存在する環境に適した消毒剤と消毒方法、ウイルス濃縮法とdirect (RT)-PCR法などのウイルスから直接核酸を増幅・検出する最新の方法などを組み合わせることで、ウイルスによる環境汚染を防御するシステムの構築が可能となった。即ち、(1)迅速かつ高率的なウイルス濃縮法と迅速かつ高感度の核酸増幅・検出法を使用して検査対象物に標的とするウイルスが汚染していないかを検査する、(2)(1)でウイルスが検出された場合もしくはウイルスによる汚染の可能性が高い場合には、当該ウイルスとそれが存在する環境に適した消毒剤と消毒方法で消毒する、(3)消毒後の検査対象物に(1)の検査法を適応させてウイルス確認検査を行うことで消毒効果を見極める、からなる一連のウイルス清浄化システムを構築し運用することで、ウイルスによる環境汚染を防御して環境を介して生じるウイルス感染の危険性を大幅に削減することが可能となり、防疫に大きく貢献できるようになった。 In addition, the latest invention to amplify and detect nucleic acids directly from viruses such as disinfectants and disinfection methods suitable for the target virus and the environment in which it exists, virus concentration method and direct (RT)-PCR method By combining methods, it became possible to build a system that protects the environment from contamination by viruses. That is, (1) a rapid and highly efficient virus concentration method and a rapid and highly sensitive nucleic acid amplification/detection method are used to test whether or not the target virus is contaminated with the target virus; If a virus is detected in (1) or if there is a high possibility of contamination with a virus, disinfect with a disinfectant and disinfection method suitable for the virus and the environment in which it exists; (3) Inspection after disinfection By applying the inspection method (1) to the target object and conducting a virus confirmation inspection to determine the disinfection effect, by constructing and operating a series of virus cleaning systems, it is possible to prevent environmental pollution by viruses and protect the environment. It has become possible to greatly reduce the risk of viral infection that occurs through the virus, and it has become possible to greatly contribute to epidemic prevention.

先に本件出願人が特許出願したウイルス濃縮法(特願2018-126772号)のようなウイルスを高率かつ安定的に濃縮して回収する方法が、標的とするウイルスとそれが存在する環境に適した消毒剤と消毒方法を評価するのに有効であることを見出し、それを使用して、効果が期待できる消毒剤と使用法を見出した。さらに、ここで見出した消毒剤と消毒法と先に記述したウイルス濃縮法と濃縮したウイルス核酸を直接(核酸の抽出・精製なしに)増幅して検出する方法とを組み合わせることで、ウイルスの存在確認から消毒、さらには消毒後の効果判定に至るシステムを構築できた。このシステムを定期的もしくは汚染が疑われる箇所で随時に実施することで、ウイルスによる環境汚染の機会を減らして、これらを介した生物(特にヒト)へのウイルス感染に対する防御力を高めることができる。 A method for concentrating and recovering viruses at a high rate and in a stable manner, such as the virus concentration method (Japanese Patent Application No. 2018-126772) filed for a patent by the applicant of the present application, is a method for collecting target viruses and the environment in which they exist. We found that it was effective in evaluating suitable disinfectants and disinfection methods, and used it to find disinfectants and methods of use that are expected to be effective. Furthermore, by combining the disinfectant and disinfection method found here with the virus concentration method described above and the method of directly amplifying and detecting the concentrated viral nucleic acid (without nucleic acid extraction/purification), the presence of the virus can be detected. We were able to build a system from confirmation to disinfection and even to determine the effect after disinfection. By implementing this system regularly or as needed at locations where contamination is suspected, it is possible to reduce the chances of environmental contamination by viruses and increase the defense against viral infections of organisms (especially humans) through these. .

検査対象物からの迅速かつ高率なウイルス濃縮法と迅速かつ高感度にウイルス中の核酸を増幅・検出する方法を組み合わせたウイルス汚染の検査やモニタリング、標的となるウイルスとそれが存在する環境に適した消毒剤と消毒方法の実施、消毒後の迅速効果判定法を組み合わせた、ウイルスによる環境汚染を防ぐためのシステムの一例を示す。Testing and monitoring of viral contamination by combining rapid and high-efficiency virus concentration methods from test objects and rapid and highly sensitive methods for amplifying and detecting nucleic acids in viruses, targeting viruses and the environment in which they exist An example of a system for preventing environmental contamination by viruses is shown, which combines a suitable disinfectant and disinfection method, and a rapid effect evaluation method after disinfection.

[実施例1]
GI & GII遺伝子タイプのNVを添加した蒸留水もしくはBSA水溶液(1% and/or 10%)の2μlに同量の塩素系消毒剤の希釈液を添加して5分間静置した後、蒸留水で100倍希釈した。希釈液に同量のグリコーゲン添加PEG溶液を加えて10分間静置後、20℃、5分間の遠心(14,000G)を行った。上清を吸引、廃棄後、残った沈渣に8μlの検体処理液を加えて懸濁し、85℃で3分間の熱処理を行った。熱処理サンプルを氷冷後、11μlの反応液を添加し、ダイレクトにreal time RT-PCRを行い、増幅に伴って蛍光標識probeが分解して生じる蛍光を計測した。結果は蛍光の立上りのサイクル数(Ct値)を2重で測定して、その平均値で示している。なお、Ct値が大きくなるほどウイルス由来の核酸量が少なくなっていて(消毒効果が出ていて)、数値が3.3大きくなるとウイルス由来の核酸量が1/10程度になったと解釈できる。
表1には消毒剤として次亜塩素酸ナトリウムを使用した結果を示している。BSA無添加では次亜塩素酸ナトリウム0.05%添加(終濃度0.025%)でNV由来RNAの増幅は認められず、強い消毒効果があることを示している。対して、BSA 1%添加(終濃度0.5%)では、次亜塩素酸ナトリウム0.2%添加(終濃度0.1%)で8~9以上サイクル分のNV由来RNA量の減少が認められるが、0.1%添加(終濃度0.05%)ではNV RNAの減少はほとんど認められず、その消毒効果はほぼ消失している。BSA 10%添加(終濃度5%)に至っては、強い消毒効果を付加するには0.8%(終濃度0.4%)の次亜塩素酸ナトリウムの添加が必要で、0.2%添加(終濃度0.1%)ではその効果が完全に消失しているなど、次亜塩素酸ナトリウムの消毒効果がBSA添加により大きく減弱することを、NVを実際に用いて(代替ウイルスではなく)検証している。
[表1]次亜塩素酸ナトリウムの消毒効果に及ぼすBSA添加の影響 [real time RT-PCRにおけるCt値(duplicateでの平均値)の比較]

Figure 0007338134000001
なお、表中の濃度表示は「添加量」を示しており、文中の添加と同じ(以下の表同様)。

表2では、同じ評価系で、二酸化塩素のNVに対する消毒効果を示している。BSA非存在下では、0.2%添加(終濃度0.1%)の二酸化塩素で、NVに対して8もしくはそれ以上サイクル分のNV RNAの減少効果を示しているが、終濃度5% BSA存在下(BSA 10%添加)では、0.4%添加(終濃度0.2%)でもその効果はほぼ消失しているなど、次亜塩素酸ナトリウムと同様にBSA添加による消毒効果の減弱が認められる。
[表2]二酸化塩素の消毒効果に及ぼすBSA添加の影響 [real time RT-PCR(duplicateでの平均値)におけるCt値の比較]
Figure 0007338134000002
表3では、同じ評価系でのクロラミンTのNVに対する消毒効果を示している。前2者に比べると、BSA添加の影響は少ないようであるが、それでもクロラミンTの2.6%添加(終濃度1.3%)において、BSA非存在下では消毒効果が認められたものの、BSA 終濃度5%存在下(BSA 10%添加)ではその効果が完全に消失しているなど、BSAの添加が消毒効果を減弱していることは明らかである。
[表3]クロラミンTの消毒効果に及ぼすBSA添加の影響 [real time RT-PCRにおけるCt値(duplicateでの平均値)の比較]
Figure 0007338134000003
[Example 1]
GI & GII genotype NV added distilled water or 2 μl of BSA aqueous solution (1% and/or 10%), add the same amount of diluted chlorine-based disinfectant solution, let it stand for 5 minutes, and then add distilled water. diluted 100 times with The same amount of glycogen-added PEG solution was added to the diluent, and after standing for 10 minutes, centrifugation (14,000 G) was performed at 20°C for 5 minutes. After the supernatant was aspirated and discarded, the remaining sediment was suspended by adding 8 μl of sample treatment solution, and heat-treated at 85° C. for 3 minutes. After ice-cooling the heat-treated sample, 11 μl of the reaction solution was added, real time RT-PCR was directly performed, and the fluorescence generated by the decomposition of the fluorescent-labeled probe accompanying the amplification was measured. The results were obtained by measuring the number of cycles (Ct value) of fluorescence rise in duplicate and showing the average value. It can be interpreted that the higher the Ct value, the lower the amount of virus-derived nucleic acids (the more the disinfection effect is obtained), and the higher the value is by 3.3, the lower the amount of virus-derived nucleic acids is to about 1/10.
Table 1 shows the results using sodium hypochlorite as the disinfectant. No amplification of NV-derived RNA was observed with the addition of 0.05% sodium hypochlorite (0.025% final concentration) without the addition of BSA, indicating a strong disinfection effect. On the other hand, with the addition of 1% BSA (0.5% final concentration), the addition of 0.2% sodium hypochlorite (0.1% final concentration) reduced the amount of NV-derived RNA for 8 to 9 or more cycles, but 0.1% When added (0.05% final concentration), almost no decrease in NV RNA was observed, and the disinfection effect almost disappeared. When adding 10% BSA (final concentration 5%), adding 0.8% (final concentration 0.4%) sodium hypochlorite is necessary to add a strong disinfection effect, and adding 0.2% (final concentration 0.1%) is necessary. ), the effect is completely lost, and it is verified that the disinfection effect of sodium hypochlorite is greatly attenuated by the addition of BSA, using NV (not an alternative virus).
[Table 1] Effect of BSA addition on the disinfection effect of sodium hypochlorite [comparison of Ct value (average value in duplicate) in real time RT-PCR]
Figure 0007338134000001
The concentration display in the table indicates the "addition amount", which is the same as the addition in the text (similar to the table below).

Table 2 shows the disinfecting effect of chlorine dioxide on NV using the same scale. In the absence of BSA, 0.2% chlorine dioxide (final concentration 0.1%) reduced NV RNA for 8 or more cycles against NV, but in the presence of 5% final BSA ( BSA 10% addition), the effect is almost lost even with 0.4% addition (final concentration 0.2%), and the attenuation of the disinfection effect due to the addition of BSA is observed as with sodium hypochlorite.
[Table 2] Effect of BSA addition on the disinfection effect of chlorine dioxide [comparison of Ct values in real time RT-PCR (average value in duplicate)]
Figure 0007338134000002
Table 3 shows the antiseptic effect of chloramine T on NV in the same evaluation system. Compared to the former two, the effect of BSA addition seems to be less. It is clear that the addition of BSA weakens the disinfection effect, such as the effect completely disappearing in the presence of 10% BSA (10% BSA added).
[Table 3] Effect of BSA addition on the disinfection effect of chloramine T [comparison of Ct value (average value in duplicate) in real time RT-PCR]
Figure 0007338134000003

[実施例2]
実施例1と同様の評価系で、メタケイ酸ナトリウムのNVに対する消毒効果を検討した結果を表4に示す。本実施例では、BSA添加の有無に関わらず、メタケイ酸ナトリウム2.2%添加(終濃度1.1%)で5~9以上サイクル分のNV RNAの減少効果が、7%濃度添加(終濃度3.5%)で9もしくはそれ以上サイクル分のRNA減少効果が認められ、22%濃度添加(終濃度11%)ではGI,GII何れのRNAも全く検出されなかった。
[表4]メタケイ酸ナトリウムの消毒効果に及ぼすBSA添加の影響 [real time RT-PCRにおけるCt値(duplicateでの平均値)の比較]

Figure 0007338134000004
また、表5ではさらに低濃度でのメタケイ酸ナトリウムのNVに対する消毒効果を検討し、1%添加(終濃度0.5%)でも弱いながらも効果が持続していることを示している。即ち、メタケイ酸ナトリウムなどのアルカリケイ酸塩は、ウイルスが存在している環境の有機物的な汚れに影響されることなく消毒効果を発揮する可能性が高く、極めて使い勝手の良い消毒剤になると判断できる。
[表5]メタケイ酸ナトリウムの消毒効果に及ぼすBSA添加の影響-2 [real time RT-PCRにおけるCt値(duplicateでの平均値)の比較]
Figure 0007338134000005
[Example 2]
Table 4 shows the results of examining the antiseptic effect of sodium metasilicate on NV using the same evaluation system as in Example 1. In this example, regardless of the presence or absence of BSA addition, the effect of reducing NV RNA for 5 to 9 or more cycles with 2.2% sodium metasilicate addition (final concentration 1.1%) was reduced to 7% concentration addition (final concentration 3.5%). At 22% concentration (11% final concentration), neither GI nor GII RNA was detected at all.
[Table 4] Effect of BSA addition on the disinfection effect of sodium metasilicate [comparison of Ct value (average value in duplicate) in real time RT-PCR]
Figure 0007338134000004
In addition, Table 5 examines the antiseptic effect of sodium metasilicate on NV at a lower concentration, and shows that the effect persists even with the addition of 1% (final concentration 0.5%), although weak. In other words, alkali silicates such as sodium metasilicate have a high possibility of exhibiting a disinfecting effect without being affected by organic dirt in the environment where the virus exists, and it is judged that it will be an extremely easy-to-use disinfectant. can.
[Table 5] Effect of BSA addition on the disinfection effect of sodium metasilicate-2 [comparison of Ct value (average value in duplicate) in real time RT-PCR]
Figure 0007338134000005

[実施例3]
実施例1と同様の評価系で、蒸留水中のNVに対しては顕著な消毒効果が認められるものの、5%BSA存在下(BSA 10%添加)でその効果が全く認められなかった濃度の次亜塩素酸ナトリウムと明らかな効果が認められる比較的低濃度のメタケイ酸ナトリウムとの併用効果を示したのが表6である。
[表6]次亜塩素酸ナトリウムとメタケイ酸ナトリウムの消毒相乗効果 [real time RT-PCRにおけるCt値(duplicateでの平均値)の比較]

Figure 0007338134000006
次亜塩素酸ナトリウムの0.2%添加(終濃度0.1%)ではBSA無添加の場合には強い消毒効果が認められるものの、BSAの添加量が増えるに従いその消毒効果が減弱し、5%BSA存在下(BSA 10%添加)では消毒効果が完全に消失している。そこに、2%(終濃度1%)のメタケイ酸ナトリウムを併用することで、BSA非存在下もしくは低濃度存在下ではメタケイ酸ナトリウム単独使用に比べて高い消毒効果を、高濃度BSA存在下では次亜塩素酸ナトリウムの消毒効果消失を防いでいることを示している。このことから、ウイルスへの消毒効果は顕著ながら有機物の存在でその効果が大きく減弱する塩素系消毒剤とアルカリ金属ケイ酸塩の併用は極めて有用性が高いことは明らかである。 [Example 3]
In the same evaluation system as in Example 1, although a significant disinfection effect was observed against NV in distilled water, the effect was not observed at all in the presence of 5% BSA (10% BSA added). Table 6 shows the effects of the combined use of sodium chlorite and relatively low-concentration sodium metasilicate, in which a clear effect is observed.
[Table 6] Synergistic disinfection effect of sodium hypochlorite and sodium metasilicate [comparison of Ct value (average value in duplicate) in real time RT-PCR]
Figure 0007338134000006
With the addition of 0.2% sodium hypochlorite (0.1% final concentration), a strong disinfection effect was observed in the absence of BSA. (10% BSA added) completely lost its disinfecting effect. There, by using 2% (final concentration 1%) sodium metasilicate in combination, in the absence of BSA or in the presence of low concentrations, a higher disinfection effect than sodium metasilicate alone is used, and in the presence of high concentrations of BSA, It shows that the disinfection effect of sodium hypochlorite is prevented from disappearing. From this, it is clear that the combined use of a chlorine-based disinfectant and an alkali metal silicate, which has a remarkable disinfecting effect against viruses but whose effect is greatly weakened by the presence of organic matter, is extremely useful.

[実施例4]
(1)検査対象物からの迅速かつ高率的なウイルス濃縮法、(2)迅速かつ高感度にウイルス中の遺伝子を増幅・検出する方法、(3)標的とするウイルスとそれが存在する環境に適した消毒剤と消毒方法、(4)消毒後の効果判定法((1)(2)の組み合わせでの)を組み合わせて、ウイルスによる環境汚染を防ぎ、これらを介した生物(特にヒト)へのウイルス感染に対する防御力を高めるシステムの一例として、NVによる食中毒の防御システムを図1に示す。
1.拭取冶具の用意
拭取り冶具は、公知の拭取り検査用の綿棒などを使用できる。
2.拭取り冶具を用いた便座裏などの拭取りによる検体採取
定期的(例えば冬季は週一回、その他の時期は月一回)もしくは随時(汚染が疑われる時など)、汚染の危険度が高い箇所(例えばトイレの便座裏)を拭き取り検体採取する。
3.上記検体の遺伝子検査など
2で拭き取り採取した検体のNVによる汚染状況を確認する。
[結果判定]4.消毒
汚染が見つかった場合(NV陽性判定)には、汚染箇所(便座裏及び周辺箇所)を中心として施設内の設備、備品、器具などを、対象物の汚れ具合に合わせて選択した消毒剤と消毒方法で消毒する。前記の作業に加えて、注意喚起と共にNV汚染が確認された施設を利用した人を中心に検便検査を実施し、陽性者が出た場合は、陰性化するまで当該者の調理作業などを控えさせるなどで、食を介したNV感染の拡大を防御する。
NV陰性判定の場合は、現在の環境に問題がある可能性は少ないため、現状維持とする。
5.消毒後の拭取り冶具を用いた便座裏などの拭取りによる検体採取
6.上記検体の遺伝子検査など
消毒後の拭き取り検査でNVが検出限界以下である(以下、消滅)を確認する。
[結果判定]再消毒と再検査が必要
NVが消滅していなかった場合(NV陽性判定)には、上記4へ戻り、消毒方法を変えて(消毒剤の濃度を高める、2度拭きの実施など)再度消毒し、消毒後にNVが消滅していることを確認する。
消毒後NV陰性判定の場合には、注意喚起と並行して経時観察などを行い、NV感染を完全に防御する。
[Example 4]
(1) A rapid and highly efficient method of concentrating viruses from test objects, (2) A method of rapidly and highly sensitively amplifying and detecting genes in viruses, (3) Target viruses and the environment in which they exist (4) Combining the disinfectant and disinfection method suitable for (4) post-disinfection evaluation method (in combination of (1) and (2)) to prevent environmental contamination by viruses, and organisms (especially humans) through these Fig. 1 shows the defense system against food poisoning caused by NV as an example of a system that enhances defenses against viral infection in .
1. Preparation of wiping jig As the wiping jig, a known swab for wiping inspection can be used.
2. Sample collection by wiping the back of the toilet seat using a wiping jig Regularly (for example, once a week in winter and once a month in other seasons) or occasionally (when contamination is suspected, etc.), the risk of contamination is high Wipe the area (e.g., under the toilet seat) to collect a sample.
3. Confirm the status of NV contamination of the samples collected by wiping in 2, such as genetic testing of the above samples.
[Result judgment]4. If disinfection contamination is found (NV positive judgment), the equipment, fixtures, instruments, etc. in the facility, centering on the contaminated area (toilet seat back and surrounding areas), are disinfected with a disinfectant selected according to the degree of contamination of the object. Disinfect with disinfectant methods. In addition to the above work, we will carry out a stool test mainly on people who have used facilities where NV contamination has been confirmed along with a warning, and if a positive person comes out, refrain from cooking work etc. Prevent the spread of NV infection through food by
In the case of NV-negative judgment, it is unlikely that there is a problem with the current environment, so the status quo is maintained.
5. 6. Specimen collection by wiping the back of the toilet seat using a wiping jig after disinfection. Confirm that NV is below the detection limit (hereafter, disappearance) by swabbing test after disinfection such as genetic test of the above specimen.
[Result judgment] Re-disinfection and re-inspection required
If the NV has not disappeared (NV positive judgment), return to 4 above, change the disinfection method (increase the concentration of the disinfectant, wipe twice, etc.) and disinfect again, and the NV disappears after disinfection. Make sure you are
In the case of NV-negative determination after disinfection, follow up over time in parallel with alerting to completely prevent NV infection.

Claims (1)

抗ウイルス消毒剤でRNAゲノムを持った標的ウイルスを処理した液に、少なくともポリエチレングリコール及びグリコーゲンを含む遠心操作でウイルスを濃縮・回収する液を加え、ウイルスを濃縮した後、該濃縮液中の標的ウイルスの遺伝子増幅を行い、消毒剤の消毒効果を判定することを特徴とするウイルス消毒効果判定方法。A solution containing at least polyethylene glycol and glycogen , which is used to concentrate and recover the virus by centrifugation, is added to the solution in which the target virus having the RNA genome has been treated with an antiviral disinfectant. A method for judging the disinfection effect of a virus, which comprises amplifying the gene of a virus and judging the disinfection effect of a disinfectant.
JP2018167537A 2018-09-07 2018-09-07 Virus disinfection effect determination method and antiviral disinfectant selected by the determination method Active JP7338134B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018167537A JP7338134B2 (en) 2018-09-07 2018-09-07 Virus disinfection effect determination method and antiviral disinfectant selected by the determination method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018167537A JP7338134B2 (en) 2018-09-07 2018-09-07 Virus disinfection effect determination method and antiviral disinfectant selected by the determination method

Publications (2)

Publication Number Publication Date
JP2020039263A JP2020039263A (en) 2020-03-19
JP7338134B2 true JP7338134B2 (en) 2023-09-05

Family

ID=69796682

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018167537A Active JP7338134B2 (en) 2018-09-07 2018-09-07 Virus disinfection effect determination method and antiviral disinfectant selected by the determination method

Country Status (1)

Country Link
JP (1) JP7338134B2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014115860A1 (en) 2013-01-25 2014-07-31 公立大学法人大阪府立大学 Virucidal agent
JP2015205234A (en) 2014-04-18 2015-11-19 有限会社クリーンケア Vomiting treatment
JP2016505273A (en) 2013-01-25 2016-02-25 ビオメリューBiomerieux Specific isolation method of nucleic acid of interest
JP2016085083A (en) 2014-10-24 2016-05-19 株式会社 島津総合サービス Microbial wipes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014115860A1 (en) 2013-01-25 2014-07-31 公立大学法人大阪府立大学 Virucidal agent
JP2016505273A (en) 2013-01-25 2016-02-25 ビオメリューBiomerieux Specific isolation method of nucleic acid of interest
JP2015205234A (en) 2014-04-18 2015-11-19 有限会社クリーンケア Vomiting treatment
JP2016085083A (en) 2014-10-24 2016-05-19 株式会社 島津総合サービス Microbial wipes

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"平成20年度 ノロウイルスの不活性化条件に関する調査", 2008, retrieved on2022.4.25, retrieved from the Internete, URL: https//www.mhlw.go.jp/topics/syokuchu/kanren/yobou/pdf/houkokusyo_110613_02.pdf
Harry Walter and Gote Johansson,Partitioning in Aqueous Two-Phase Systems: An Overview.,Anal. Biochem.,1986年06月,Vol.155, No.2,p.215-242,doi: 10.1016/0003-2697(86)90431-8
加藤 好雄,APTP(水性二層分配)法 巨大分子の新しい分離・精製法,化学と生物,Vol.8, No.5,1970年05月25日,p.304-312,doi: 10.1271/kagakutoseibutsu1962.8.304
山本 茂貴、野田 衛,平成20年度 ノロウイルスの不活化条件に関する調査,ノロウイルスの不活化条件に関する調査(国立医薬品食品衛生研究所食品衛生管理部),2008年,https//www.mhlw.go.jp/topics/syokuchu/kanren/yobou/pdf/houkokusyo_110613_02.pdf
日本食品微生物学会雑誌, 2013, Vol.30, pp.156-159
船越 久司,グリコーゲン添加エタノール沈殿法によるノロウイルスの濃縮分離法,日本食品微生物学会雑誌,2013年09月30日,Vol.30, No.3,p.156-159,https://doi.org/10.5803/jsfm.30.156

Also Published As

Publication number Publication date
JP2020039263A (en) 2020-03-19

Similar Documents

Publication Publication Date Title
Silverman et al. Systematic review and meta-analysis of the persistence and disinfection of human coronaviruses and their viral surrogates in water and wastewater
Lombardi et al. Inactivation of avian influenza virus using common detergents and chemicals
Warnes et al. Inactivation of norovirus on dry copper alloy surfaces
Magalhães et al. Cheese-related listeriosis outbreak, Portugal, March 2009 to February 2012
Bibby et al. Ebola virus persistence in the environment: state of the knowledge and research needs
Wigginton et al. Emerging investigators series: the source and fate of pandemic viruses in the urban water cycle
Onyango et al. Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004
Xiao et al. Wastewater pathogen surveillance based on One Health approach
Wolfe et al. Detection of monkeypox viral DNA in a routine wastewater monitoring program
Tamaki et al. Virucidal effect of acidic electrolyzed water and neutral electrolyzed water on avian influenza viruses
Cook et al. The disinfection characteristics of Ebola virus outbreak variants
Ghernaout et al. Environmental engineering for stopping viruses pandemics
Song et al. Comparison of virucidal efficacy of sodium hypochlorite, chlorine dioxide, peracetic acid, and ethanol against hepatitis A virus by carrier and suspension tests
Pan et al. SARS-CoV-2 on surfaces and HVAC filters in dormitory rooms
Liu et al. Duration of SARS-CoV-2 positive in quarantine room environments: A perspective analysis
Karami et al. Investigation of SARS-CoV-2 virus on nozzle surfaces of fuel supply stations in North West of Iran
Habibi et al. A safe and effective sample collection method for assessment of SARS-CoV-2 in aerosol samples
Gul et al. Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial
Goda et al. Inactivation of human norovirus by chlorous acid water, a novel chlorine-based disinfectant
Taha et al. Environmental detection and spreading of mpox in healthcare settings: a narrative review
Makary et al. Multiple norovirus outbreaks among workplace canteen users in Finland, July 2006
JP7338134B2 (en) Virus disinfection effect determination method and antiviral disinfectant selected by the determination method
Tung-Thompson et al. Persistence of human norovirus RT-qPCR signals in simulated gastric fluid
US10969309B2 (en) Virus concentration method
Huang et al. Avian influenza A (H5N6) virus detected during live-poultry market surveillance linked to a human infection in Changsha, China, from 2020 to 2023

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180910

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210804

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220428

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220728

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221018

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230525

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230801

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230807

R150 Certificate of patent or registration of utility model

Ref document number: 7338134

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150